MKMasamitsu Kobayashi

Masamitsu Kobayashi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Masamitsu Kobayashi has a total of 138 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Efficacy of Nonpharmacological Interventions for Caregiver Burden and Positive Aspects of Caregiving Among Informal Caregivers of People With Dementia: A Systematic Review and Network Meta‐Analysis

    by Yoshiyasu Ito, Michihiro Tsubaki, Kohei Kajiwara, Masamitsu Kobayashi, Hideaki Sakuramoto, Makoto Yamanaka, Jun Kako, Takahiro Kakeda

    Objectives: To systematically evaluate and compare the efficacy of nonpharmacological interventions in reducing caregiver burden and enhancing positive aspects of caregiving (PAC) among informal caregivers of inidviduals with dementia using network meta‐analysis (NMA). Methods: This systematic review and NMA followed PRISMA‐NMA guidelines. Six databases (PubMed, Scopus, Web of Science, CENTRAL, PsycINFO, and CINAHL) were searched. Randomised controlled trials evaluating nonpharmacological interventions for informal caregivers of individuals with dementia were included. Outcomes were caregiver burden and/or PAC assessed using instruments. A random‐effects frequentist NMA estimated standardised mean differences (SMDs) and 95% confidence intervals (CIs). Heterogeneity and inconsistency were examined, and treatments were ranked using P‐scores. A sensitivity analysis excluding studies at high overall risk of bias was performed, and confidence in the evidence was assessed using CINeMA. Results: Sixty‐seven trials met the inclusion criteria; 43 studies were included in the caregiver burden network, and seven in the PAC network. Multicomponent interventions significantly reduced caregiver burden compared with control (SMD: −0.33; 95% CI: −0.63 to −0.04). Other interventions did not demonstrate statistically significant effects. Seven studies reported PAC outcomes. Because the PAC evidence was sparse and contained no closed loops, PAC findings were synthesised narratively without statistical pooling. Study‐level effects varied across intervention comparisons and assessment time points, and the limited evidence was insufficient to identify an effective intervention. Conclusions: Multicomponent interventions show the most effective evidence for reducing caregiver burden, whereas no clearly effective strategy was identified for enhancing PAC. Further research should focus on theory‐driven interventions and standardised outcome measures.

  • The 2025 revision of JPOS/JASCC clinical guidelines for delirium in adult patients with cancer: a summary of recommendations

    by Yoshinobu Matsuda, Jun Kako, Takaaki Hasegawa, Saho Wada, Hitoshi Tanimukai, Shinichiro Inoue, Kaori Shinsato, Yusuke Kanno, Tetsuro Ishida, Yuichi Kitaura, et al.

    Background: The Japan Psycho-Oncology Society and the Japanese Association of Supportive Care in Cancer revised the clinical practice guidelines for delirium in adult patients with cancer in 2025. In this article, we describe the guideline revision and summarize the updated recommendations. Methods: These guidelines were developed in accordance with the Minds Manual for Clinical Practice Guideline Development 2020. The multidisciplinary guideline development group formulated four new clinical questions (CQs) addressing delirium prevention (ramelteon and orexin receptor antagonists) and management (combination therapies of antipsychotics with either benzodiazepines or antihistamines). In addition, systematic reviews of 11 existing CQs were updated. Results: Multicomponent interventions were strongly recommended for delirium prevention, based on moderate-certainty evidence. Bright light therapy, antipsychotics, ramelteon, and orexin receptor antagonists were not recommended for prevention. For delirium management, antipsychotics, trazodone, the combination of antipsychotics and benzodiazepines, and opioid switching were suggested, whereas hydroxyzine, benzodiazepines alone, and the combination of antipsychotics and antihistamines were not recommended. All recommendations for delirium management were weak, with low- to very-low-certainty evidence. Background questions addressed delirium assessment tools, precipitating factors, non-pharmacological interventions, and interventions for terminally ill patients. Conclusions: These revised clinical practice guidelines can serve as a practical framework for optimizing prevention, assessment, and management of delirium in adult patients with cancer in Japan.

  • Open Access

    Prevalence of depressive disorder and clinically relevant depressive symptoms among family caregivers of people with dementia: a systematic review and meta-analysis protocol (Preprint)

    by Kohei Kajiwara, Yoshiyasu Ito, Michihiro Tsubaki, Makoto Yamanaka, Masamitsu Kobayashi, Hideaki Sakuramoto, Jun Kako, Takahiro Kakeda

    BACKGROUND Family caregivers provide much of the day-to-day care and support to people living with dementia. In this population, depression is common, yet prevalence estimates vary widely. This variation partly reflects inconsistent use of the term depression to describe distinct outcomes: depressive disorders identified by structured or semi-structured diagnostic interviews and clinically relevant depressive symptoms defined by rating-scale cutoffs. These outcomes are related but should not be treated as equivalent. OBJECTIVE This systematic review/meta-analysis aims to estimate separately the prevalence of depressive disorders and clinically relevant depressive symptoms among adult family caregivers of people with dementia, and to examine variation by assessment method, depression instrument, cutoff, caregiver characteristics, care context, and study characteristics. METHODS We will conduct a systematic review and meta-analysis of English-language studies published since January 1, 2000, searching PubMed, CINAHL, Scopus, and the Web of Science. Where feasible, backward citation searching and forward citation tracking will also be performed. Eligible studies will include unpaid adult family caregivers providing direct care or support to relatives, spouses, or partners with dementia; studies of paid or professional caregivers will be excluded. The primary outcomes will be the prevalence of (1) depressive disorder based on structured or semi-structured diagnostic interviews or established diagnostic criteria and (2) clinically relevant depressive symptoms based on validated depression measures with clearly reported cut-off values; outcomes will be analyzed separately. Where sufficient data are available, ultra-brief screening tools (e.g., Patient Health Questionnaire-2) will be synthesized separately from longer depression scales. Two reviewers will independently screen studies, extract data, and assess risk of bias using the Joanna Briggs Institute Checklist for Prevalence Studies. Where appropriate, pooled prevalence estimates with 95% confidence intervals will be calculated using random-effects generalized linear mixed models with a logit link. Heterogeneity will be assessed using Cochran’s Q, I², between-study variance, and prediction intervals, as appropriate, and prespecified subgroup, meta-regression, and sensitivity analyses will explore potential sources of heterogeneity. RESULTS The protocol was prospectively registered on the Open Science Framework before formal screening. The database search, study selection, data extraction, risk-of-bias assessment, and meta-analysis will be conducted post-registration. Results will follow the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 statement. The OSF-registered systematic review is expected to be completed by March 2027. CONCLUSIONS This review will provide separate prevalence estimates for depressive disorders and clinically relevant depressive symptoms among family caregivers of people with dementia. Distinguishing diagnostic interview-based disorders from scale-based symptom classifications and detailing instruments and cutoffs may clarify evidence for research, clinical assessment, and service planning. CLINICALTRIAL OSF registration number: 10.17605/OSF.IO/QZES3.

  • Effectiveness of non-pharmacological interventions for chemotherapy-induced peripheral neuropathy–related pain: A systematic review and network meta-analysis

    by Masamitsu Kobayashi, Jun Kako, Hideaki Sakuramoto, Takahiro Kakeda, Yoshiyasu Ito, Kohei Kajiwara, Michihiro Tsubaki, Makoto Yamanaka


  • Psychotherapeutic Techniques for Dyspnea in Cancer and Chronic Illness: Systematic Review

    by Jun Kako, Kohei Kajiwara, Masamitsu Kobayashi, Yoshiyasu Ito, Kanako Ichikura, Yoshinobu Matsuda, Takashi Yamaguchi

  • Open Access

    Nonpharmacological Interventions by Nurses for Chemotherapy‐Induced Skin Toxicity: A Scoping Review

    by Mariko Niino, Miho Suzuki, Yoichi Shimizu, Yusuke Kanno, Kimiko Nakano, Kohei Kajiwara, Masamitsu Kobayashi, Miharu Morikawa, Yoshinobu Matsuda, Megumi Hori, et al.

    Objective: This scoping review aimed to categorize nonpharmacological interventions targeted at chemotherapy‐induced skin toxicities, specifically implemented by nurses in clinical settings. Methods: A comprehensive literature search was performed in PubMed, CINAHL, Cochrane Central Register of Controlled Trials, and Ichushi‐Web from database inception to April 3, 2026. Two independent reviewers analyzed the study selection, data extraction, and classification of dermatologic toxicity types and intervention modalities. Results: Of the 1499 studies that were screened, 48 met the inclusion criteria. The nonpharmacological interventions targeted five primary skin toxicities: 19 for alopecia, 15 for hand–foot syndrome (HFS)/palmar–plantar erythrodysesthesia, 7 for acneiform rash, 6 for onychosis and nail discoloration, and 2 for dry skin. The interventions included scalp cooling, frozen gloves/socks, herbal decoctions, topical agents, remote symptom monitoring, and self‐care education via skincare diaries. Nonpharmacological interventions for alopecia and HFS were predominant, whereas research on other chemotherapy‐induced skin toxicities, including periungual inflammation and skin dryness, was limited. Conclusions: There are diverse nonpharmacological interventions for chemotherapy‐induced skin toxicities. Few studies have explored structured patient self‐care education, despite its crucial role in ensuring intervention adherence. Further research on less‐studied conditions and the role of nurses in implementing these interventions is needed.

  • Reply to: ‘Factors Influencing Whether Patients and Caregivers Wish to Have a Dementia Diagnosis Disclosed’

    by Kohei Kajiwara, Maki Kanaoka, Jun Kako, Masamitsu Kobayashi, Yasuhide Etou, Teppei Yamashita, Makoto Yamanaka


  • Nursing Support for Nonpharmacological Interventions to Prevent Delirium in Patients with Cancer: A Scoping Review

    by Yusuke Kanno, Kimiko Nakano, Kohei Kajiwara, Masamitsu Kobayashi, Miharu Morikawa, Yoshinobu Matsuda, Yoichi Shimizu, Mariko Niino, Miho Suzuki, Taichi Shimazu, et al.

    Introduction: The importance of nonpharmacological interventions in preventing delirium is well documented in several guidelines; however, research specifically detailing nursing support in oncology remains sparse. This scoping review aimed to identify nursing support for nonpharmacological interventions to prevent delirium in patients with cancer. Methods: Utilizing Arksey and O’Malley’s six-stage scoping review framework and adhering to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses-ScR checklist, we systematically searched PubMed, CINAHL, CENTRAL, and Ichushi-Web databases from their inception to January 31, 2022, with an update on August 31, 2023. Additional relevant studies were identified through manual searches of key journals and article lists. Studies that reported on patients with cancer aged ≥18 years, interventions for preventing delirium, nursing support, and quantitative data showing outcomes were included. Results: A total of 794 articles were screened, and 10 met the inclusion criteria. Among these, six were randomized controlled trials (RCTs) and four were non-RCTs. The thematic analysis categorized nursing support into four components: (1) multicomponent interventions, (2) bright light therapy, (3) specialist team approaches, and (4) family support. Most interventions were applied during surgical procedures and were effective in preventing postoperative delirium, especially multicomponent interventions and bright light therapy. Conclusion: This review highlights that nursing support for delirium prevention in patients with cancer encompasses multicomponent interventions, bright light therapy, specialist team approaches, and family support. Future research should examine the effectiveness of this nursing support using systematic reviews and meta-analyses and explore the feasibility of implementing it in nursing practice.


  • Open Access

    Nursing Practice for Patients with Cancer Pain with Predicted Prognosis of Months or Weeks: A Multicenter Cross-Sectional Study in Japan

    by Miharu Morikawa, Masamitsu Kobayashi, Kohei Kajiwara, Kimiko Nakano, Yusuke Kanno, Yoshinobu Matsuda, Jun Kako

    Background: Nonpharmacological therapies implemented by nurses in clinical practice for patients with cancer pain remain unclear. Objective: To investigate nursing support for patients with cancer pain in Japanese palliative care units (PCUs). Design: Nationwide online survey. Setting/Subjects: Registered nurses in Japanese PCUs. Measurements: Herein, we conducted a questionnaire survey to assess the frequency of care implementation for 23 nursing support items for patients with cancer pain with prognoses anticipated in the scale of weeks or months, asking nurses working in PCUs to respond anonymously. We did not perform statistical tests on the results, instead of calculating descriptive statistics on implementation frequencies. Results: We requested surveys from 389 PCUs nationwide and 162 participated. Of 2,448 invited nurses, 539 (22.3%) responded. The implementation frequencies for the 23 nursing support items were almost the same for patients with prognosis anticipated in the scale of weeks or months. Approximately 80% frequently provide comfort care (environmental adjustment/mental health care/oral care) and adjust postures and positions. Conversely, support options frequently implemented by <20% of the participants included progressive muscle relaxation therapy, guided imagery therapy, combined therapy, cognitive behavioral intervention, reflexology, self-administered acupressure, exercise, poetry appreciation, auricular acupressure, relaxation using virtual reality, and reiki. Conclusion: Our findings indicate that comfort care and positioning adjustments are frequently provided for patients with cancer with prognosis anticipated in the scale of weeks or months to improve well-being. Nursing support practices requiring specialized skills were less frequently implemented. These results offer insights for expanding palliative care support options.


  • Open Access

    Exploring Psychotherapy Approaches for Dyspnea: A Systematic Review Protocol

    by Jun Kako, Kohei Kajiwara, Masamitsu Kobayashi, Yoshiyasu Ito, Kanako Ichikura, Yoshinobu Matsuda, Takashi Yamaguchi

    Introduction: Dyspnea, a common and debilitating symptom, affects over half of the patients with cancer, with increasing frequency and severity as the end of life approaches. It substantially affects the daily lives of patients by contributing to anxiety, depression, fatigue, and reduced physical activity, ultimately diminishing their quality of life. Although pharmacological treatments remain standard, nonpharmacological interventions, including psychotherapy, are increasingly recommended owing to their safety and accessibility. Psychotherapy is particularly relevant for alleviating psychological distress associated with dyspnea; however, research on its efficacy in managing dyspnea among patients with cancer is limited. This systematic review aims to synthesize evidence on the following four key psychotherapy techniques for managing dyspnea: mindful breathing, guided imagery, progressive muscle relaxation, and meditation. The review will assess the optimal delivery methods, evaluate the quality of existing studies, and provide clinical recommendations for implementing these interventions in cancer care. Method and Analysis: This review adheres to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses protocols. A systematic search will be conducted on some databases such as PubMed. Relevant studies will also be identified through reference lists and manual searches of key journals. The search terms will include keywords related to dyspnea and psychotherapeutic techniques. Four independent reviewers will screen and assess the articles, extracting data using a standardized charting form. The quality of the studies will be assessed using the Mixed Methods Assessment Tool. The results will be summarized via a psychotherapeutic technique, providing a comprehensive overview of the interventions and their applicability.